InsidersTradesSigma
Follow the 益盛药业 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 益盛药业 has logged 1 reports. Market capitalisation: €2.2bn. The latest transaction was reported on 6 June 2025 (Sale). Among the most active insiders: 薛晓民. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€399,903
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,700 of 28,752 companies
42.2
score / 100
Value38
Quality47
FCF yld3.9%
Earn yld1.3%
EV/EBITDA30.2x
ROE1.4%
Gross mgn74%
Net mgn4.5%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 June 2025
About 益盛药业
益盛药业 is a healthcare and pharmaceutical company listed on the XSHE market. It specializes in the development and production of innovative medications.